🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Joel Greenblatt’s XBI Holdings & Trades

First Buy
Q3 2026
Duration Held
1 Quarters
Largest Add
Q3 2026
+4,617 Shares
Current Position
4,617 Shares
$728,009 Value

Joel Greenblatt's XBI Position Overview

Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 4,617 shares of State Street SPDR S&P Biotech ETF (XBI) worth $728,009, representing 0.00% of the portfolio. First purchased in 2026-Q3, this recently established position has been held for 1 quarters.

Based on recent 13F filings, Joel Greenblatt has initiated a new position in XBI, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.

Analysis based on 13F filings available since 2013 Q2

Joel Greenblatt's State Street SPDR S&P Biotech ETF (XBI) Holding Value Over Time

Track share changes against reported price movement

Quarterly State Street SPDR S&P Biotech ETF (XBI) Trades by Joel Greenblatt

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 +4,617 New Buy 4,617 $157.68

Joel Greenblatt's State Street SPDR S&P Biotech ETF Investment FAQs

Joel Greenblatt first purchased State Street SPDR S&P Biotech ETF (XBI) in Q3 2026, acquiring 4,617 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Joel Greenblatt has held State Street SPDR S&P Biotech ETF (XBI) for 1 quarters since Q3 2026.

Joel Greenblatt's largest addition to State Street SPDR S&P Biotech ETF (XBI) was in Q3 2026, adding 4,617 shares worth $728,009.

According to the latest 13F filing for Q3 2026, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 4,617 shares of State Street SPDR S&P Biotech ETF (XBI), valued at approximately $728,009.

As of the Q3 2026 filing, State Street SPDR S&P Biotech ETF (XBI) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.

Joel Greenblatt's peak holding in State Street SPDR S&P Biotech ETF (XBI) was 4,617 shares, as reported at the end of Q3 2026.